Cargando…
The revolution of the anti-diabetic drugs in cardiology
Beginning in December 2008, under the auspices of Food and Drug Administration, numerous controlled clinical trial were planned, and in part completed, concerning the cardiovascular (CV) effects of hypoglycaemic drug in patients with Type 2 diabetes mellitus. At least 9 studies have been concluded,...
Autores principales: | Verdecchia, Paolo, Angeli, Fabio, Cavallini, Claudio, Aita, Adolfo, Turturiello, Dario, Reboldi, Gianpaolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270967/ https://www.ncbi.nlm.nih.gov/pubmed/32523463 http://dx.doi.org/10.1093/eurheartj/suaa084 |
Ejemplares similares
-
Electrocardiography for diagnosis of left ventricular hypertrophy in hypertensive patients with atrial fibrillation
por: Angeli, Fabio, et al.
Publicado: (2019) -
Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry
por: Angeli, Fabio, et al.
Publicado: (2019) -
Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension
por: Verdecchia, Paolo, et al.
Publicado: (2017) -
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later
por: Angeli, Fabio, et al.
Publicado: (2021) -
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
por: Reboldi, Gianpaolo, et al.
Publicado: (2009)